A detailed history of Carlson Capital L P transactions in Chimerix Inc stock. As of the latest transaction made, Carlson Capital L P holds 114,000 shares of CMRX stock, worth $973,559. This represents 0.38% of its overall portfolio holdings.

Number of Shares
114,000
Holding current value
$973,559
% of portfolio
0.38%

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2025

May 14, 2025

BUY
$3.25 - $8.51 $370,500 - $970,140
114,000 New
114,000 $970,000

Others Institutions Holding CMRX

About CHIMERIX INC


  • Ticker CMRX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 87,622,896
  • Market Cap $748M
  • Description
  • Chimerix, Inc., a biopharmaceutical company, develops medicines to enhance the lives of patients living with serious diseases. The company's approved product is TEMBEXA (brincidofovir), a lipid conjugate through inhibition of viral DNA synthesis that is developed as a medical countermeasure for smallpox. Its clinical stage development programs i...
More about CMRX
Track This Portfolio

Track Carlson Capital L P Portfolio

Follow Carlson Capital L P and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Carlson Capital L P, based on Form 13F filings with the SEC.

News

Stay updated on Carlson Capital L P with notifications on news.